BioCryst Pharmaceuticals Inc (STU:BO1) Stock News, Headlines & Updates
BioCryst Pharmaceuticals Inc Stock News from GuruFocus
- 1
- 2
- 3
Jul 21, 2025
BioCryst Pharmaceuticals Inc (BCRX) Announces Upcoming Q2 2025 Financial Results Release | BCRX stock news
GuruFocus News • 6:06am
BioCryst to Report Second Quarter 2025 Financial Results on August 4
Marketwired • 6:00am
Jul 09, 2025
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit | BCRX Stock News
GuruFocus News • 6:18am
BioCryst Pharmaceuticals Inc (BCRX) Unveils New Research on HAE Treatment Burdens at 2025 US HAEA National Summit | BCRX stock news
GuruFocus News • 6:04am
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit
Marketwired • 6:00am
Jul 07, 2025
BioCryst Pharmaceuticals Inc (BCRX) Appoints New CFO to Drive Growth | BCRX stock news
GuruFocus News • 7:07am
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
Marketwired • 7:00am
BioCryst Pharmaceuticals (BCRX) Appoints New CFO, Babar Ghias
GuruFocus News • 6:58am
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development | BCRX Stock News
GuruFocus News • 6:17am
Jul 03, 2025
BioCryst Pharmaceuticals Inc (BCRX) Announces Grant of Restricted Stock Units to New Employees | BCRX stock news
GuruFocus News • 7:03am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 7:00am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BCRX Stock News
GuruFocus News • 6:15am
Jul 01, 2025
BioCryst Pharma (BCRX) Receives Boost with Increased Price Target | BCRX Stock News
GuruFocus News • 9:02am
Jun 30, 2025
BioCryst Pharma (BCRX) Maintains Outperform Rating and $13 Price Target | BCRX Stock News
GuruFocus News • 9:32am
BCRX Stock Rating and Price Target Update by Wedbush | BCRX Stock News
GuruFocus News • 8:30am
Jun 27, 2025
BioCryst Pharmaceuticals (BCRX) Receives Reiterated Buy Rating from Needham | BCRX Stock News
GuruFocus News • 12:30pm
BioCryst Pharmaceuticals Sells European ORLADEYO Business for $264 Million | BCRX stock news
GuruFocus News • 8:07am
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
Marketwired • 7:00am
BioCryst Pharmaceuticals (BCRX) to Divest European Orladeyo Business for $264M
GuruFocus News • 6:57am
BioCryst Pharmaceuticals (BCRX) Projects Strong Cash Position by 2027 | BCRX Stock News
GuruFocus News • 6:17am
BioCryst (BCRX) to Divest European ORLADEYO Business for $264 Million | BCRX Stock News
GuruFocus News • 6:17am
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million | BCRX Stock News
GuruFocus News • 6:16am
Jun 25, 2025
BioCryst Pharma (BCRX) Maintains "Buy" Rating from Needham | BCRX Stock News
GuruFocus News • 11:00am
Jun 16, 2025
BioCryst (BCRX) Showcases Promising Results for ORLADEYO in HAE Treatment | BCRX Stock News
GuruFocus News • 6:31am
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI | BCRX Stock News
GuruFocus News • 6:19am
BioCryst Pharmaceuticals Inc (BCRX) Announces Promising Long-term Data for ORLADEYO in HAE Treatment | BCRX stock news
GuruFocus News • 6:02am
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI
Marketwired • 6:00am
Jun 13, 2025
BCRX: BioCryst's ORLADEYO Approved in Colombia for HAE Prevention | BCRX Stock News
GuruFocus News • 6:17am
ORLADEYO® (berotralstat) Approved in Colombia | BCRX Stock News
GuruFocus News • 6:17am
BioCryst Pharmaceuticals Inc (BCRX) Gains Approval for ORLADEYO in Colombia | BCRX stock news
GuruFocus News • 6:03am
ORLADEYO® (berotralstat) Approved in Colombia
Marketwired • 6:00am
Jun 06, 2025
BioCryst (BCRX) Gains Approval in Netherlands for ORLADEYO | BCRX Stock News
GuruFocus News • 6:31am
BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries | BCRX Stock News
GuruFocus News • 6:17am
BioCryst Pharmaceuticals Inc (BCRX) Secures Reimbursement for ORLADEYO® in the Netherlands | BCRX stock news
GuruFocus News • 6:01am
BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
Marketwired • 6:00am
Jun 03, 2025
BioCryst Pharmaceuticals Inc (BCRX) Shares Up 3.59% on Jun 3
GuruFocus News • 12:19pm
BioCryst Pharmaceuticals Inc (BCRX) Announces Grant of Restricted Stock Units to New Employees | BCRX stock news
GuruFocus News • 7:09am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 7:00am
BioCryst (BCRX) Awards Restricted Stock Units to New Employees | BCRX Stock News
GuruFocus News • 6:30am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BCRX Stock News
GuruFocus News • 6:17am
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news